Major Neurocognitive Disorder Clinical Trials

5 recruiting

Major Neurocognitive Disorder Trials at a Glance

6 actively recruiting trials for major neurocognitive disorder are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Chuncheon, Milan, and Montreal. Lead sponsors running major neurocognitive disorder studies include CHU de Quebec-Universite Laval, Casa di Cura IGEA, and Eastern Switzerland University of Applied Sciences.

Browse major neurocognitive disorder trials by phase

About Major Neurocognitive Disorder Clinical Trials

Looking for clinical trials for Major Neurocognitive Disorder? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Major Neurocognitive Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Major Neurocognitive Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.

Mild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)Major Neurocognitive Disorder+1 more
Casa di Cura IGEA390 enrolled1 locationNCT06701630
Recruiting
Not Applicable

Exergaming Revolution in Dementia

Alzheimer DiseaseParkinson DiseaseLewy Body Dementia+2 more
Eastern Switzerland University of Applied Sciences48 enrolled1 locationNCT06631742
Recruiting
Not Applicable

Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders

DementiaMajor Neurocognitive Disorder
HAII corp.ltd122 enrolled3 locationsNCT06615167
Recruiting
Not Applicable

GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders

Major Neurocognitive Disorder
CHU de Quebec-Universite Laval400 enrolled2 locationsNCT04889794
Recruiting
Phase 2

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

DementiaAlzheimer DiseaseMajor Neurocognitive Disorder With Aggressive Behavior
Eastern Virginia Medical School40 enrolled1 locationNCT04436081
Recruiting

Perioperative Enhancement of Cognitive Trajectory (The PROTECT trial)

Postoperative Neurocognitive DisorderMild Neurocognitive DisorderDelirium+1 more
The University of Melbourne692 enrolled1 locationACTRN12619001778178